Thursday, March 30, 2023
Time: 11:00 AM-12:00 PM EST
Experts from CROs, patient advocacy, and the pharmaceutical industry will share insights on the role of decentralised clinical trials (DCTS) as a potential option to make clinical research more accessible to participants who may not otherwise be able to participate. The panel will discuss important topics, such as:
- Stakeholder engagement and resources needed to determine if a DCT is an optimal option to improve trial accessibility
- What capabilities are needed to successful execute a DCT through the lens of accessibility
Moderator:
![](https://icon.widen.net/content/13cf2971-c3c3-4a56-bd8d-14d801e77665/web/Chakamian-Afshawn-(1).png?crop=yes&w=240&h=240&itok=zg8TliID)
Afshawn Chakamian
Director of Therapeutic Expertise, ICON plc
Panelists:
![](https://icon.widen.net/content/f95e1e00-1e84-4628-ace9-a304a4a0b218/web/Bharadia_Ashmee-(002).png?crop=yes&w=240&h=240&itok=ChEIbFz6)
Ashmee Bharadia
Vice President, In Home Services, Accellacare
![](https://icon.widen.net/content/155576de-86c9-4f15-83eb-6e5bd21765e0/web/Dave_Sneha.png?crop=yes&w=240&h=240&itok=7BaejOLO)
Sneha Dave
Executive Director, Generation Patient
![](https://icon.widen.net/content/163a39a8-7fbf-4365-b448-9ce24ff4ce26/web/Lipset_Craig.png?crop=yes&w=240&h=240&itok=hpGI10sb)
Craig Lipset
Co-Chair, Decentralized Trials & Research Alliance, Adjunct Assistant Professor, Rutgers University, Vice President, Foundation for Sarcoidosis Research, Managing Partner, Clinical Innovation Partners
![](https://icon.widen.net/content/55724958-5272-4356-bb82-1d36f9d326a1/web/Wright_Katie.png?crop=yes&w=240&h=240&itok=JO37rRp7)
Katie Wright
Person living with VEDS; Host of Staying Connected podcast